A new study highlights the importance of Pap smear tests for early cervical cancer detection in India. Despite the test's simplicity and the fact that it costs less than many routine medical ...

Final phase 3 trial results confirm a survival benefit with the immunotherapy cemiplimab (Libtayo) when used for the second-line treatment of recurrent or metastatic cervical cancer. They come from ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Compared with a dorsal approach, a ventral surgical ...

According to the NHS, some of the most common barriers to cervical screening attendance included embarrassment, anxiety, a lack of understand, concerns about pain, busy schedules and fear of results.

Camrelizumab/famitinib combination significantly improved PFS and OS over platinum-based chemotherapy in recurrent/metastatic ...

Results from a phase 3 trial showing prolonged survival with the immunotherapy cemiplimab (Libtayo) in the second-line treatment of recurrent or metastatic cervical cancer are being hailed as ...

Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study ...

Xiamen Innovax Biotech Co., Ltd. ("INNOVAX") participated in the 37th International Papillomavirus Society (IPVS) Conference, and hosted a dedicated ...

Ministry of Health has announced that it has embarked on a multi-age cohort cervical cancer vaccination campaign targeting ...

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study Patients received nivolumab 240 mg every 2 weeks.

The first Indian state to provide free HPV vaccines to girls aged 1-14, Tamil Nadu advances cervical cancer prevention ...